Emicizumab Biosimilar - Research Grade

Human

Factor IX + Factor X

5mg/ml

Human IgG4-kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human Factor IX and Factor X

Blue ice

Coagulation factors IX and X are central proteases of the intrinsic clotting cascade, of enduring interest in haemostasis and haemophilia research. Built as an unconjugated, non-therapeutic analog of emicizumab, this bispecific recombinant antibody bridges factor IX and factor X and is supplied strictly for research use only (RUO). It is manufactured to in vivo standards, carries low endotoxin, and is offered in scalable milligram (mg) to gram (g) batches for heavy-usage and high-throughput facilities. Applications include functional assays, factor-bridging and clotting studies, reproducible controls, and in vivo coagulation models requiring well-defined, dependable bispecific reagents.

P00740;P00742

ICH3002

https://www.imgt.org/mAb-DB/